Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are male or female and aged 18 or older
- People who have been diagnosed with acromegaly (a condition caused by a pituitary tumour that leads to too much growth hormone), confirmed by elevated growth hormone and/or IGF-I levels in the blood
- People whose IGF-I levels remain above 80% of the upper limit of the normal range, despite being on a stable dose of medication for at least 4 months
- People who are willing and able to provide written informed consent to participate
Who may not be able to join:
- People who are pregnant or breastfeeding
- People who are currently being treated with a medication called pegvisomant
- People who have had pituitary surgery or radiation therapy within the 6 months before joining the study
- People who are expected to need pituitary surgery or radiation therapy at any point during the study
- People who have a history of epilepsy or currently have epilepsy
- People who have taken part in a clinical trial of an experimental drug or medical device within the 30 days before screening
- People who have a mental health condition that makes it difficult to understand what the study involves and what participating could mean for them
- People whose HbA1c (a blood test that measures average blood sugar levels over time) is above 6.5% at the screening stage
- People who are taking any diabetes medication other than metformin
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +31 0107033055
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
IGF-1
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.